diclofenac has been researched along with Scalp Dermatoses in 5 studies
Diclofenac: A non-steroidal anti-inflammatory agent (NSAID) with antipyretic and analgesic actions. It is primarily available as the sodium salt.
diclofenac : A monocarboxylic acid consisting of phenylacetic acid having a (2,6-dichlorophenyl)amino group at the 2-position.
Scalp Dermatoses: Skin diseases involving the SCALP.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Ingenol mebutate (IngMeb) and diclofenac sodium (DS) are approved treatments for actinic keratosis (AK)." | 9.27 | Phase IV head-to-head randomized controlled trial comparing ingenol mebutate 0·015% gel with diclofenac sodium 3% gel for the treatment of actinic keratosis on the face or scalp. ( Harwood, CA; Larsson, T; Serra-Guillén, C; Skov, T; Stockfleth, E; Østerdal, ML, 2018) |
| "Ingenol mebutate (IngMeb) and diclofenac sodium (DS) are approved treatments for actinic keratosis (AK)." | 5.27 | Phase IV head-to-head randomized controlled trial comparing ingenol mebutate 0·015% gel with diclofenac sodium 3% gel for the treatment of actinic keratosis on the face or scalp. ( Harwood, CA; Larsson, T; Serra-Guillén, C; Skov, T; Stockfleth, E; Østerdal, ML, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Stockfleth, E | 1 |
| Harwood, CA | 1 |
| Serra-Guillén, C | 1 |
| Larsson, T | 1 |
| Østerdal, ML | 1 |
| Skov, T | 1 |
| Mazzella, C | 1 |
| Greco, V | 1 |
| Costa, C | 1 |
| Scalvenzi, M | 1 |
| Russo, D | 1 |
| Savastano, R | 1 |
| Staibano, S | 1 |
| Fabbrocini, G | 1 |
| Zane, C | 1 |
| Facchinetti, E | 1 |
| Rossi, MT | 1 |
| Specchia, C | 1 |
| Calzavara-Pinton, PG | 1 |
| Malvehy, J | 1 |
| Roldán-Marín, R | 1 |
| Iglesias-García, P | 1 |
| Díaz, A | 1 |
| Puig, S | 1 |
| Smith, SR | 1 |
| Morhenn, VB | 1 |
| Piacquadio, DJ | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Efficacy and Safety of Ingenol Mebutate Gel 0.015% Compared to Diclofenac Sodium Gel 3% in Subjects With Actinic Keratoses on the Face or Scalp[NCT02406014] | Phase 4 | 502 participants (Actual) | Interventional | 2015-04-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 trials available for diclofenac and Scalp Dermatoses
2 other studies available for diclofenac and Scalp Dermatoses
| Article | Year |
|---|---|
Management of clinical and subclinical actinic keratoses with histological and immunohistochemical assessments by confocal microscopy.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antimetabolites, Antineoplastic; Diclofenac; Fluorouracil; | 2018 |
Monitoring treatment of field cancerisation with 3% diclofenac sodium 2.5% hyaluronic acid by reflectance confocal microscopy: a histologic correlation.
Topics: Administration, Cutaneous; Anti-Inflammatory Agents, Non-Steroidal; Biopsy; Diclofenac; Drug Therapy | 2015 |